This is a preview of subscription content, log in via an institution to check access.
Reference
Delacruz W, et al. Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature. Case Reports in Oncological Medicine 2016: 2016. Available from: URL: http://doi.org/10.1155/2016/2596423 - USA
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1633, 534 (2017). https://doi.org/10.1007/s40278-017-24802-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-24802-1